• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNA 测序揭示肝细胞癌发病机制的分子机制。

Molecular mechanisms of pathogenesis in hepatocellular carcinoma revealed by RNA‑sequencing.

机构信息

Department of Infectious Diseases, Baoji Municipal Central Hospital, Baoji, Shaanxi 721008, P.R. China.

出版信息

Mol Med Rep. 2017 Nov;16(5):6674-6682. doi: 10.3892/mmr.2017.7457. Epub 2017 Sep 11.

DOI:10.3892/mmr.2017.7457
PMID:28901494
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5865798/
Abstract

The present study aimed to explore the underlying molecular mechanisms of hepatocellular carcinoma (HCC). RNA‑sequencing profiles GSM629264 and GSM629265, from the GSE25599 data set, were downloaded from the Gene Expression Omnibus database and processed by quality evaluation. GSM629264 and GSM629265 were from HCC and adjacent non‑cancerous tissues, respectively. TopHat software was used for alignment analysis, followed by the detection of novel splicing sites. In addition, the Cufflinks software package was used to analyze gene expressions, and the Cuffdiff program was used to screen for differently expressed genes (DEGs) and differentially expressed splicing variants. Gene ontology functional enrichment and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses of DEGs were also performed. Transcription factors (TFs) and microRNAs (miRNAs) that regulate DEGs were identified, and a protein‑protein interaction (PPI) network was constructed. The hub node in the PPI network was obtained, and the TFs and miRNAs that regulated the hub node were further predicted. The quality of the sequencing data met the standards for analysis, and the clean reads were ~65%. Most sequencing reads mapped into coding sequence exons (CDS_exons), whereas other reads mapped into exon 3' untranslated regions (UTR_Exons), 5'UTR_Exons and Introns. Upregulated and downregulated DEGs between HCC and adjacent non‑cancerous tissues were screened. Genes of differentially expressed splicing variants were identified, including vesicle‑associated membrane protein 4, phosphatidylinositol glycan anchor biosynthesis class C, protein disulfide isomerase family A member 4 and growth arrest specific 5. Screened DEGs were enriched in the complement pathway. In the PPI network, ubiquitin C (UBC) was the hub node. UBC was predicted to be regulated by several TFs, including specificity protein 1 (SP1), FBJ murine osteosarcoma viral oncogene homolog (FOS), proto‑oncogene c‑JUN (JUN), FOS‑like antigen 2 (FOSL2) and SWI/SNF‑related, matrix‑associated, actin‑dependent regulator of chromatin, subfamily A, member 4 (SMARCA4), and several miRNAs, including miR‑30 and miR‑181. Results from the present study demonstrated that UBC, SP1, FOS, JUN, FOSL2, SMARCA4, miR‑30 and miR‑181 may participate in the development of HCC.

摘要

本研究旨在探索肝细胞癌(HCC)的潜在分子机制。从 Gene Expression Omnibus 数据库中下载 GSE25599 数据集的 RNA-seq 谱 GSM629264 和 GSM629265,经过质量评估后进行处理。GSM629264 和 GSM629265 分别来自 HCC 和相邻的非癌组织。使用 TopHat 软件进行比对分析,随后检测新的剪接位点。此外,使用 Cufflinks 软件包分析基因表达,并使用 Cuffdiff 程序筛选差异表达基因(DEGs)和差异表达剪接变体。还对 DEGs 进行了基因本体功能富集和京都基因与基因组百科全书通路富集分析。鉴定调控 DEGs 的转录因子(TFs)和 microRNAs(miRNAs),构建蛋白质-蛋白质相互作用(PPI)网络。获得 PPI 网络中的枢纽节点,并进一步预测调控枢纽节点的 TFs 和 miRNAs。测序数据的质量符合分析标准,清洁读数约为 65%。大多数测序读数映射到编码序列外显子(CDS_exons),而其他读数映射到外显子 3'非翻译区(UTR_Exons)、5'UTR_Exons 和内含子。筛选 HCC 和相邻非癌组织之间的上调和下调 DEGs。鉴定差异表达剪接变体的基因,包括囊泡相关膜蛋白 4、磷酸肌醇聚糖锚生物合成类 C、蛋白二硫键异构酶家族 A 成员 4 和生长停滞特异性 5。筛选的 DEGs 富集在补体途径中。在 PPI 网络中,泛素 C(UBC)是枢纽节点。预测 UBC 受几个 TFs 调控,包括特异性蛋白 1(SP1)、FBJ 鼠骨肉瘤病毒癌基因同源物(FOS)、原癌基因 c-JUN(JUN)、FOS 样抗原 2(FOSL2)和 SWI/SNF 相关、基质相关、肌动蛋白依赖性染色质调节剂亚家族 A,成员 4(SMARCA4)和几个 miRNAs,包括 miR-30 和 miR-181。本研究结果表明,UBC、SP1、FOS、JUN、FOSL2、SMARCA4、miR-30 和 miR-181 可能参与 HCC 的发生发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff2e/5865798/b22d635227da/mmr-16-05-6674-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff2e/5865798/54fd9f167175/mmr-16-05-6674-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff2e/5865798/bc7cd2522922/mmr-16-05-6674-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff2e/5865798/b22d635227da/mmr-16-05-6674-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff2e/5865798/54fd9f167175/mmr-16-05-6674-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff2e/5865798/bc7cd2522922/mmr-16-05-6674-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff2e/5865798/b22d635227da/mmr-16-05-6674-g04.jpg

相似文献

1
Molecular mechanisms of pathogenesis in hepatocellular carcinoma revealed by RNA‑sequencing.RNA 测序揭示肝细胞癌发病机制的分子机制。
Mol Med Rep. 2017 Nov;16(5):6674-6682. doi: 10.3892/mmr.2017.7457. Epub 2017 Sep 11.
2
Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.基于生物信息学分析和实验验证鉴定肝癌中与侵袭转移相关的 microRNAs。
J Transl Med. 2018 Sep 29;16(1):266. doi: 10.1186/s12967-018-1639-8.
3
Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.通过生物信息学分析鉴定与肝细胞癌相关的枢纽基因,CYP2C8 是一个有潜力的预后生物标志物。
Gene. 2019 May 25;698:9-18. doi: 10.1016/j.gene.2019.02.062. Epub 2019 Feb 27.
4
Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.基于生物信息学分析的肝细胞癌关键基因和微小RNA的鉴定与相互作用分析
World J Surg Oncol. 2017 Mar 16;15(1):63. doi: 10.1186/s12957-017-1127-2.
5
The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.通过高通量数据的生物信息学分析鉴定肝细胞癌中的关键基因和信号通路。
Med Oncol. 2017 Jun;34(6):101. doi: 10.1007/s12032-017-0963-9. Epub 2017 Apr 21.
6
Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.鉴定参与 HBV 相关 HCC 发病机制的潜在 miRNA-mRNA 调控网络。
J Transl Med. 2019 Jan 3;17(1):7. doi: 10.1186/s12967-018-1761-7.
7
Key signaling pathways, genes and transcription factors associated with hepatocellular carcinoma.与肝细胞癌相关的关键信号通路、基因和转录因子。
Mol Med Rep. 2018 Jun;17(6):8153-8160. doi: 10.3892/mmr.2018.8871. Epub 2018 Apr 12.
8
Long non-coding RNAs and genes contributing to the generation of cancer stem cells in hepatocellular carcinoma identified by RNA sequencing analysis.通过RNA测序分析鉴定出的与肝细胞癌中癌症干细胞生成相关的长链非编码RNA和基因。
Oncol Rep. 2016 Nov;36(5):2619-2624. doi: 10.3892/or.2016.5120. Epub 2016 Sep 22.
9
Screening and Functional Prediction of Key Candidate Genes in Hepatitis B Virus-Associated Hepatocellular Carcinoma.乙型肝炎病毒相关性肝细胞癌关键候选基因的筛选与功能预测。
Biomed Res Int. 2020 Oct 9;2020:7653506. doi: 10.1155/2020/7653506. eCollection 2020.
10
Bioinformatics analysis of different candidate genes involved in hepatocellular carcinoma induced by HepG2 cells or tumor cells of patients.不同候选基因在 HepG2 细胞或患者肿瘤细胞诱导的肝细胞癌中的生物信息学分析。
J Int Med Res. 2020 Jun;48(6):300060520932112. doi: 10.1177/0300060520932112.

引用本文的文献

1
m6A methyltransferase METTL14‑mediated RP1‑228H13.5 promotes the occurrence of liver cancer by targeting hsa‑miR‑205/ZIK1.m6A 甲基转移酶 METTL14 介导的 RP1-228H13.5 通过靶向 hsa-miR-205/ZIK1 促进肝癌的发生。
Oncol Rep. 2024 Apr;51(4). doi: 10.3892/or.2024.8718. Epub 2024 Mar 1.
2
Phosphatidylinositol glycan anchor biosynthesis, class C is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma.磷脂酰肌醇聚糖锚定生物合成C类是一种预后生物标志物,与肝细胞癌中的免疫浸润相关。
Front Genet. 2022 Aug 19;13:899407. doi: 10.3389/fgene.2022.899407. eCollection 2022.
3
Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma patients.

本文引用的文献

1
Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT).卵巢高钙血症型小细胞癌(SCCOHT)中肿瘤抑制因子SMARCA4的缺失。
Rare Dis. 2014 Nov 3;2(1):e967148. doi: 10.4161/2167549X.2014.967148. eCollection 2014.
2
A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases.两阶段肝切除术治疗初始不可切除结直肠癌肝转移的系统评价。
HPB (Oxford). 2013 Jul;15(7):483-91. doi: 10.1111/j.1477-2574.2012.00607.x. Epub 2012 Nov 7.
3
NCBI GEO: archive for functional genomics data sets--update.
针对肝细胞癌患者中 SARS-CoV-2 感染的靶点和药物预测。
PLoS One. 2022 May 31;17(5):e0269249. doi: 10.1371/journal.pone.0269249. eCollection 2022.
4
MKL1 regulates hepatocellular carcinoma cell proliferation, migration and apoptosis via the COMPASS complex and NF-κB signaling.MKL1 通过 COMPASS 复合物和 NF-κB 信号通路调控肝癌细胞的增殖、迁移和凋亡。
BMC Cancer. 2021 Nov 6;21(1):1184. doi: 10.1186/s12885-021-08185-w.
5
Specific MiRNAs in naïve T cells associated with Hepatitis C Virus-induced Hepatocellular Carcinoma.与丙型肝炎病毒诱导的肝细胞癌相关的初始T细胞中的特定微小RNA。
J Cancer. 2021 Jan 1;12(1):1-9. doi: 10.7150/jca.49594. eCollection 2021.
6
GPI-AP: Unraveling a New Class of Malignancy Mediators and Potential Immunotherapy Targets.糖基磷脂酰肌醇锚定蛋白:揭示一类新型的恶性肿瘤介质及潜在的免疫治疗靶点
Front Oncol. 2020 Dec 4;10:537311. doi: 10.3389/fonc.2020.537311. eCollection 2020.
7
Aging Science Talks: The role of miR-181a in age-related loss of muscle mass and function.衰老科学讲座:miR-181a在与年龄相关的肌肉质量和功能丧失中的作用。
Transl Med Aging. 2020;4:81-85. doi: 10.1016/j.tma.2020.07.001. Epub 2020 Jul 8.
8
The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways.HBV 相关肝细胞癌(HBV-HCC)和免疫途径中乙型肝炎病毒 X 蛋白(HBx)失调 microRNA 的多种作用。
Viruses. 2020 Jul 10;12(7):746. doi: 10.3390/v12070746.
9
MicroRNA-197-3p acts as a prognostic marker and inhibits cell invasion in hepatocellular carcinoma.微小RNA-197-3p作为一种预后标志物,抑制肝细胞癌的细胞侵袭。
Oncol Lett. 2019 Feb;17(2):2317-2327. doi: 10.3892/ol.2018.9848. Epub 2018 Dec 18.
10
Potential biomarkers of HCC based on gene expression and DNA methylation profiles.基于基因表达和DNA甲基化谱的肝癌潜在生物标志物。
Oncol Lett. 2018 Sep;16(3):3183-3192. doi: 10.3892/ol.2018.9020. Epub 2018 Jun 26.
NCBI GEO:功能基因组学数据集存档 - 更新。
Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5. doi: 10.1093/nar/gks1193. Epub 2012 Nov 27.
4
Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin.肝癌的发生是由 AP-1 通过 SIRT6 依赖的抑制生存素来控制的。
Nat Cell Biol. 2012 Nov;14(11):1203-11. doi: 10.1038/ncb2590. Epub 2012 Oct 7.
5
microRNA-181a represses ox-LDL-stimulated inflammatory response in dendritic cell by targeting c-Fos.miRNA-181a 通过靶向 c-Fos 抑制 ox-LDL 刺激的树突状细胞炎症反应。
J Lipid Res. 2012 Nov;53(11):2355-63. doi: 10.1194/jlr.M028878. Epub 2012 Sep 5.
6
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma.体细胞突变和局灶性拷贝数变化的综合分析鉴定了肝细胞癌中的关键基因和途径。
Nat Genet. 2012 May 6;44(6):694-8. doi: 10.1038/ng.2256.
7
Androgen pathway stimulates microRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis.雄激素通路刺激 microRNA-216a 转录,抑制早期肝癌发生中的抑癌基因 lung cancer-1 基因。
Hepatology. 2012 Aug;56(2):632-43. doi: 10.1002/hep.25695. Epub 2012 Jun 11.
8
Serum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseases.血清代谢组学揭示了肝癌和慢性肝病中脂肪酸代谢的失调。
Anal Bioanal Chem. 2012 Apr;403(1):203-13. doi: 10.1007/s00216-012-5782-4. Epub 2012 Feb 14.
9
RNA-Seq analyses generate comprehensive transcriptomic landscape and reveal complex transcript patterns in hepatocellular carcinoma.RNA-Seq 分析生成全面的转录组图谱,并揭示肝细胞癌中的复杂转录模式。
PLoS One. 2011;6(10):e26168. doi: 10.1371/journal.pone.0026168. Epub 2011 Oct 17.
10
SWI/SNF nucleosome remodellers and cancer.SWI/SNF 核小体重塑因子与癌症。
Nat Rev Cancer. 2011 Jun 9;11(7):481-92. doi: 10.1038/nrc3068.